Icon to close the modal
Support
Sales
Phone Icon
1.844.8.BD.LIFE (1.844.823.5433)
Modal Close Icon
Sales Form
Please fill out the form and a sales representative will get in touch with you.

Capability:

Product Line:

Icon to close thank you modal
Thank you for contacting our sales team!
A sales representive will get in touch with you shortly.
Ordering
Phone Icon
1.714.283.2228
5 a.m. to 4 p.m. PT
Fax Icon
1.714.283.8424
oem@carefusion.com
Customer Service
Phone Icon
1.844.8.BD.LIFE (1.844.823.5433)
Fax Icon
1.800.847.2220
Port Access Kits with GuardIVa™ Antimicrobial Hemostatic IV Dressing
Contact Us navigation arrow
Carousel Image
Loading
tabs dropdown arrow
Overview
  • Designed to standardize port access procedures
  • Provides the convenience of necessary kit components in a common package
  • Kit components are organized to facilitate sterile “best practices” for port access related procedures
  • Assists clinicians in complying with guidelines for sterile port access outlined by nursing societies and the CDC
  • Procedural Checklist included in every kit:
    • Educate and assist in sterile port access technique
    • Convenient documentation and tracking of port access procedure
    • Procedural checklist for simplified protocol documentation

The GuardIVa® dressing significantly lowered re-growth of skin microflora at day 7 and day 10 compared to the control.1

true

Port access related implications

For the patient

  • Port removal
  • Chemotherapy/treatment interruption
  • Hospital in-patient stay
  • Secondary complications from infection
  • Placement of a 2nd device that may not offer the benefits of a port

For the facility

  • Port removal
  • Potential hospital stay
  • Additional procedures and devices
  • Less or lack of reimbursement due to recent CMS changes regarding central line infections
Your Answer for Port Access
Checklist
Your Answer for Port Access

Checklist for Bard Port access Kit

Download
Port Access Kits
Now Offering
Port Access Kits

Port Access Kits with GuardIVa Antimicrobial Hemostatic IV Dressing

Learn more

Port-Access Technique

Proper Port-Access Technique Matters

Nearly 80% of Oncology Nurses surveyed by Bard cite poor sterile technique, site prep or access procedures as the likely cause for port access related infections.†

Help clinicians to meet the following:

  • Centers for Disease Control (CDC) Guidelines

  • Infusion Nursing Society (INS) Standards of Practice

  • Oncology Nursing Society (ONS) Guidelines

  • Occupational Safety & Health Administration

     (OSHA) Guidelines

  • The Joint Commission (JCAHO) National Patient Safety Goals

Availability

BD Port Access Kit

Available in the following safety infusion set configurations:


  • MiniLoc™ Safety Infusion Set
  • SafeStep™ Huber Needle Set
  • PowerLoc™ Safety Infusion Set
  • PowerLoc™ Max Safety Infusion Set
Reference

1. As demonstrated through in vivo testing. Data on file.

Vescia, S. et al., Management of Venous Port Systems in Oncology: A review of current evidence, Annals of Oncology, Sept 2007, 19:9-15.

Groeger, Jeffrey S. et.al., Infectious Morbidity Associated with Long-Term Use of Venouos Access Devices in Patients with Cancer, Annals of Internal Medicine, 1993; 119:1168-1174.

Grannan, Kevin I., et.al., Early and Late Complications of Totally Implantable Venous Access Devices, Journal of Surgical Oncology, 1990, 44:52-54.

Pegeus, David, et.al., Comparison of Infections in Hickman and Implanted Port Catheters in Adult Solid Tumor Patients, Journal of Surgical Oncology, 49: 156-162 (1992). Groeger, Jeffrey S. et.al., Venous Access in the Cancer Patient, Principles and Practice of Oncology, 1991; vol. 5 no. 3

† Survey results on file at C. R. Bard, Inc.

Please go to the product specific page to find the Safety Information link for inserts and labels, as well as indications, directions for use, contraindications, hazards, warnings, and precautions.

true
Products & Accessories
  • product-image

    SafeStep® Huber Needle Set PAK + GuardIVa® Dressing, 19 G x .75 in

  • product-image

    SafeStep® Huber Needle Set PAK + GuardIVa® Dressing with NAC® Needleless Access Y-Site, 19 G x .75 in

  • product-image

    SafeStep® Huber Needle Set PAK + GuardIVa® Dressing, 20 G x 1 in

  • product-image

    SafeStep® Huber Needle Set PAK + GuardIVa® Dressing with NAC® Needleless Access Y-Site, 20 G x 1 in

  • product-image

    SafeStep® Huber Needle Set PAK + GuardIVa® Dressing, 22 G x 1 in

  • product-image

    SafeStep® Huber Needle Set PAK + GuardIVa® Dressing with NAC® Needleless Access Y-Site, 22 G x 1 in

  • product-image

    SafeStep® Huber Needle Set PAK + GuardIVa® Dressing with NAC® Needleless Access Y-Site, 22 G x 1.5 in

  • product-image

    SafeStep® Huber Needle Set PAK + GuardIVa® Dressing, 22 G x 1.5 in

  • product-image

    SafeStep® Huber Needle Set PAK + GuardIVa® Dressing, 20 G x .75 in

  • product-image

    SafeStep® Huber Needle Set PAK + GuardIVa® Dressing with NAC® Needleless Access Y-Site, 20 G x .75 in

  • product-image

    SafeStep® Huber Needle Set PAK + GuardIVa® Dressing, 20 G x 1.5 in

  • product-image

    SafeStep® Huber Needle Set PAK + GuardIVa® Dressing with NAC® Needleless Access Y-Site, 20 G x 1.5 in

  • product-image

    SafeStep® Huber Needle Set PAK + GuardIVa® Dressing, 19 G x 1.5 in

  • product-image

    SafeStep® Huber Needle Set PAK + GuardIVa® Dressing with NAC® Needleless Access Y-Site, 19 G x 1.5 in

  • product-image

    SafeStep® Huber Needle Set PAK + GuardIVa® Dressing with NAC® Needleless Access Y-Site, 19 G x 1 in

  • product-image

    SafeStep® Huber Needle Set PAK + GuardIVa® Dressing, 19 G x 1 in

  • product-image

    SafeStep® Huber Needle Set PAK + GuardIVa® Dressing with NAC® Needleless Access Y-Site, 22 G x .75 in

  • product-image

    SafeStep® Huber Needle Set PAK + GuardIVa® Dressing, 22 G x .75 in

  • product-image

    MiniLoc® Safety Infusion Set PAK + GuardIVa® Dressing, 19 G x 1.5 in

  • product-image

    MiniLoc® Safety Infusion Set PAK + GuardIVa® Dressing with Y-Injection Site, 19 G x 1.5 in

  • product-image

    PowerLoc® Safety Infusion Set PAK + GuardIVa® Dressing with Y-Injection Site, 19 G x 1 in

  • product-image

    PowerLoc® Safety Infusion Set PAK + GuardIVa® Dressing, 19 G x 1 in

  • product-image

    PowerLoc® MAX Power-Injectable Infusion Set PAK + GuardIVa® Dressing, 19 G x 1.5 in

  • product-image

    PowerLoc® MAX Power-Injectable Infusion Set PAK + GuardIVa® Dressing with Y-Injection Site, 19 G x 1.5 in

  • product-image

    PowerLoc® Safety Infusion Set PAK + GuardIVa® Dressing, 19 Gauge x 1.5"

  • product-image

    MiniLoc® Safety Infusion Set PAK + GuardIVa® Dressing with Y-Injection Site, 22 G x 1.5 in

  • product-image

    MiniLoc® Safety Infusion Set PAK + GuardIVa® Dressing, 22 G x 1.5 in

  • product-image

    PowerLoc® Safety Infusion Set PAK + GuardIVa® Dressing with Y-Injection Site, 22 G x 1.5 in

  • product-image

    PowerLoc® Safety Infusion Set PAK + GuardIVa® Dressing, 22 G x 1.5 in

  • product-image

    PowerLoc® MAX Power-Injectable Infusion Set PAK + GuardIVa® Dressing with Y-Injection Site, 22 G x 1 in

  • product-image

    PowerLoc® MAX Power-Injectable Infusion Set PAK + GuardIVa® Dressing, 22 G x 1 in

  • product-image

    PowerLoc® MAX Power-Injectable Infusion Set PAK + GuardIVa® Dressing with Y-Injection Site, 22 G x 1.5 in

  • product-image

    PowerLoc® MAX Power-Injectable Infusion Set PAK + GuardIVa® Dressing, 22 G x 1.5 in

  • product-image

    MiniLoc® Safety Infusion Set PAK + GuardIVa® Dressing with Y-Injection Site, 22 G x .75 in

  • product-image

    MiniLoc® Safety Infusion Set PAK + GuardIVa® Dressing, 22 G x .75 in

  • product-image

    MiniLoc® Safety Winged Set PAK + GuardIVa® Dressing with Y-Injection Site, 22 G x 1 in

  • product-image

    MiniLoc® Safety Infusion Set PAK + GuardIVa® Dressing, 22 G x 1 in

  • product-image

    MiniLoc® Safety Infusion Set PAK + GuardIVa® Dressing, 20 G x .75 in

  • product-image

    MiniLoc® Safety Infusion Set PAK + GuardIVa® Dressing with Y-Injection Site, 20 G x 1.5 in

  • product-image

    MiniLoc® Safety Infusion Set PAK + GuardIVa® Dressing, 20 G x 1.5 in

  • product-image

    MiniLoc® Safety Infusion Set PAK + GuardIVa® Dressing with Y-Injection Site, 20 G x 1 in

  • product-image

    MiniLoc® Safety Infusion Set PAK + GuardIVa® Dressing, 20 G x 1 in

  • product-image

    PowerLoc® MAX Power-Injectable Infusion Set PAK + GuardIVa® Dressing with Y-Injection Site, 20 G x 1 in

  • product-image

    PowerLoc® MAX Power-Injectable Infusion Set PAK + GuardIVa® Dressing, 20 G x 1 in

  • product-image

    PowerLoc® MAX Power-Injectable Infusion Set PAK + GuardIVa® Dressing, 19 G x 1 in

  • product-image

    PowerLoc® MAX Power-Injectable Infusion Set PAK + GuardIVa® Dressing with Y-Injection Site, 19 G x 1 in

  • product-image

    PowerLoc® MAX Power-Injectable Infusion Set PAK + GuardIVa® Dressing, 20 G x 1.5 in

  • product-image

    PowerLoc® MAX Power-Injectable Infusion Set PAK + GuardIVa® Dressing with Y-Injection Site, 20 G x 1.5 in

  • product-image

    PowerLoc® Safety Infusion Set PAK + GuardIVa® Dressing with Y-Injection Site, 22 G x 1 in

  • product-image

    PowerLoc® Safety Infusion Set PAK + GuardIVa® Dressing, 22 G x 1 in

  • product-image

    MiniLoc® Safety Infusion Set PAK + GuardIVa® Dressing with Y-Injection Site, 19 G x 1 in

  • product-image

    MiniLoc® Safety Infusion Set PAK + GuardIVa® Dressing, 19 G x 1 in

  • product-image

    PowerLoc® Safety Infusion Set PAK + GuardIVa® Dressing with Y-Injection Site, 20 G x 1 in

  • product-image

    PowerLoc® Safety Infusion Set PAK + GuardIVa® Dressing, 20 G x 1 in

  • product-image

    MiniLoc® Safety Infusion Set PAK + GuardIVa® Dressing, 19 G x .75 in

  • product-image

    MiniLoc® Safety Infusion Set PAK + GuardIVa® Dressing with Y-Injection Site, 19 G x .75 in

  • product-image

    PowerLoc® Safety Infusion Set PAK + GuardIVa® Dressing, 20 G x 1.5 in

  • product-image

    PowerLoc® Safety Infusion Set PAK + GuardIVa® Dressing with Y-Injection Site, 20 G x 1.5 in

References

1. As demonstrated through in vivo testing. Data on file.

Vescia, S. et al., Management of Venous Port Systems in Oncology: A review of current evidence, Annals of Oncology, Sept 2007, 19:9-15.

Groeger, Jeffrey S. et.al., Infectious Morbidity Associated with Long-Term Use of Venouos Access Devices in Patients with Cancer, Annals of Internal Medicine, 1993; 119:1168-1174.

Grannan, Kevin I., et.al., Early and Late Complications of Totally Implantable Venous Access Devices, Journal of Surgical Oncology, 1990, 44:52-54.

Pegeus, David, et.al., Comparison of Infections in Hickman and Implanted Port Catheters in Adult Solid Tumor Patients, Journal of Surgical Oncology, 49: 156-162 (1992). Groeger, Jeffrey S. et.al., Venous Access in the Cancer Patient, Principles and Practice of Oncology, 1991; vol. 5 no. 3

† Survey results on file at C. R. Bard, Inc.

Please go to the product specific page to find the Safety Information link for inserts and labels, as well as indications, directions for use, contraindications, hazards, warnings, and precautions.

true
Resources
References

1. As demonstrated through in vivo testing. Data on file.

Vescia, S. et al., Management of Venous Port Systems in Oncology: A review of current evidence, Annals of Oncology, Sept 2007, 19:9-15.

Groeger, Jeffrey S. et.al., Infectious Morbidity Associated with Long-Term Use of Venouos Access Devices in Patients with Cancer, Annals of Internal Medicine, 1993; 119:1168-1174.

Grannan, Kevin I., et.al., Early and Late Complications of Totally Implantable Venous Access Devices, Journal of Surgical Oncology, 1990, 44:52-54.

Pegeus, David, et.al., Comparison of Infections in Hickman and Implanted Port Catheters in Adult Solid Tumor Patients, Journal of Surgical Oncology, 49: 156-162 (1992). Groeger, Jeffrey S. et.al., Venous Access in the Cancer Patient, Principles and Practice of Oncology, 1991; vol. 5 no. 3

† Survey results on file at C. R. Bard, Inc.

Please go to the product specific page to find the Safety Information link for inserts and labels, as well as indications, directions for use, contraindications, hazards, warnings, and precautions.

true
Frequently Asked Questions
false
Description Kit
Huber Needle 1
Syringe, Sodium Chloride (Saline) 0.9%, 10mL 1
Dressing, Transparent 1
Gauze Pad, 2 in. x 2 in. 4
Gloves, Non-Latex, Sterile 2
Procedure Checklist 1
Mask 1
Prep Pad, Alcohol 1
Prep Pad, Skin Protectant 1
Tape Strips, Anchor (3 per) 1
Towel, Absorbent 1
Dressing Change Label 1
GuardIVa® Antimicrobial Hemostatic IV Dressing 1

 

Reference

1. As demonstrated through in vivo testing. Data on file.

Vescia, S. et al., Management of Venous Port Systems in Oncology: A review of current evidence, Annals of Oncology, Sept 2007, 19:9-15.

Groeger, Jeffrey S. et.al., Infectious Morbidity Associated with Long-Term Use of Venouos Access Devices in Patients with Cancer, Annals of Internal Medicine, 1993; 119:1168-1174.

Grannan, Kevin I., et.al., Early and Late Complications of Totally Implantable Venous Access Devices, Journal of Surgical Oncology, 1990, 44:52-54.

Pegeus, David, et.al., Comparison of Infections in Hickman and Implanted Port Catheters in Adult Solid Tumor Patients, Journal of Surgical Oncology, 49: 156-162 (1992). Groeger, Jeffrey S. et.al., Venous Access in the Cancer Patient, Principles and Practice of Oncology, 1991; vol. 5 no. 3

† Survey results on file at C. R. Bard, Inc.

Please go to the product specific page to find the Safety Information link for inserts and labels, as well as indications, directions for use, contraindications, hazards, warnings, and precautions.

true
Chat with us
Our live chat is available between the hours of 8.30am - 5.00pm EST, Monday - Friday
×